KRAS and neoplasm: A western blot (WB) assay revealed markedly reduced expression levels of KRAS and KRAS G12S mutant proteins in the tumor tissues of A549 cells-engrafted mice edited by AdV-Cas9-sgG12S, but not in the AdV-Cas9 treated control group.